Citation Impact
Citing Papers
A comparison of recombinant Hirudin with Heparin for the treatment of acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators
1996
Determinants of disease and disability in the elderly: The Rotterdam elderly study
1991
The Metabolic Syndrome and Inflammation
2004
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Acute Coronary Care in the Elderly, Part I
2007
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
2002 Standout
The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1
1994 StandoutNature
Primary Prevention of Coronary Heart Disease in Women through Diet and Lifestyle
2000 Standout
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Value of Acute Rest Sestamibi Perfusion Imaging for Evaluation of Patients Admitted to the Emergency Department With Chest Pain
1997
Unstable angina: Pathogenesis, diagnosis, and treatment
1993
Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention
2003
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
2011 Standout
Aspirin, Heparin, and Fibrinolytic Therapy in Suspected Acute Myocardial Infarction
1997
Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia
1995
Intravenous nitroglycerin-induced heparin resistance: A qualitative antithrombin III abnormality
1990
The metabolic syndrome
2010 Standout
A new regimen for heparin use in acute coronary syndromes
1999
A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women
2000
New Antithrombotic Drugs
2012
Platelet-Active Drugs
1998
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
C-Reactive Protein Levels and Outcomes after Statin Therapy
2005 Standout
Low-Molecular-Weight Heparin (Fragmin) During Instability in Coronary Artery Disease (FRISC)
1997
Irregular coronary lesion morphology after thrombolysis predicts early clinical instability
1991
Effects of Prior Aspirin and Anti-Ischemic Therapy on Outcome of Patients With Unstable Angina 11This study was supported by Biogen, Inc., Cambridge, Massachusetts. Manuscript received July 28, 1997; revised manuscript received and accepted December 1, 1997.
1998
A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease
1994 Standout
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis
2004 Standout
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
1995 Standout
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Coordinated Transcription of Key Pathways in the Mouse by the Circadian Clock
2002 Standout
Unstable Angina Pectoris
2000
Myocardial infarction patients in the 1990s—their risk factors, stratification and survival in Canada: The Canadian assessment of myocardial infarction (CAMI) study
1996
2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
2012
Reactivation of Unstable Angina after the Discontinuation of Heparin
1992
Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes
1999
Restenosis after coronary angioplasty: A multilvariate statistical model to relate lesion and procedure variables to restenosis
1991
A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease
1999 Standout
Platelet Activation and Atherothrombosis
2007 Standout
The metabolic syndrome
2005 Standout
Treatment with Bivalirudin (Hirulog) as Compared with Heparin during Coronary Angioplasty for Unstable or Postinfarction Angina
1995
Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
1993 Standout
Antiplatelet Drugs
2008
Unstable Angina: Good Long-Term Outcome After a Complicated Early Course
1998
The Use of Aspirin in Ischemic Heart Disease
1992
Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the antithrombotic therapy in acute coronary syndromes study group)
1990
Protective and Damaging Effects of Stress Mediators
1998 Standout
Design and Methodology of the PURSUIT Trial
1997
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Antithrombotic Therapy for Non–ST-Segment Elevation Acute Coronary Syndromes
2008
Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent era
2010
Heparin and Low-Molecular-Weight Heparin
1998
Intravenous heparin dosing
1993
Aspirin and Mortality from Coronary Bypass Surgery
2002
A dose-finding study of fondaparinux in patients with non–ST-segment elevation acute coronary syndromes
2004
Guidelines for Percutaneous Coronary Interventions
2005
Hospital Volume and Surgical Mortality in the United States
2002 Standout
Circadian Variation of Fibrinolytic Activity in Blood
1991
Evidence for Prevention of Death and Myocardial Infarction With Platelet Membrane Glycoprotein IIb/IIIa Receptor Blockade by Abciximab (c7E3 Fab) Among Patients With Unstable Angina Undergoing Percutaneous Coronary Revascularization fn1fn1This study was supported by Centocor, Inc., Malvern, Pennsylvania.
1997
Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults
1999 Standout
Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era
2006
Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban
2001
Coronary lesion morphology in acute myocardial infarction: Demonstration of early remodeling after streptokinase treatment
1990
C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy
1998
Platelet Hyperreactivity and Prognosis in Survivors of Myocardial Infarction
1990
The Determinants of Activated Partial Thromboplastin Time, Relation of Activated Partial Thromboplastin Time to Clinical Outcomes, and Optimal Dosing Regimens for Heparin Treated Patients with Acute Coronary Syndromes: A Review of GUSTO-IIb
2002
Heparin
1991
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
1997 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
2001 Standout
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
1997 Standout
Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable angina
1994
Percutaneous Transluminal Coronary Angioplasty
1994
Hemorrhagic Complications of Anticoagulant Treatment
1998
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
2000 Standout
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
1994 Standout
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina
1990
Antiplatelet agents for the treatment and prevention of atherothrombosis
2011
Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis
2000
Hemorrhagic Complications of Anticoagulant Treatment
2004
Platelet-Active Drugs
2001
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
2004
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes
1998 Standout
A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable Angina
1998
The Weight-based Heparin Dosing Nomogram Compared with a Standard Care Nomogram
1993
Statewide Quality Improvement Initiatives and Mortality After Cardiac Surgery
1997
Effect of Thromboxane A 2 Blockade on Clinical Outcome and Restenosis After Successful Coronary Angioplasty
1995
Antithrombotic therapy in cardiac disease. An emerging approach based on pathogenesis and risk.
1989
PAI-1 and the Metabolic Syndrome
2006
Comparison of Low-Molecular-Weight Heparin With Unfractionated Heparin Acutely and With Placebo for 6 Weeks in the Management of Unstable Coronary Artery Disease
1997
Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction
1999
Association of Chronic Stress With Plasminogen Activator Inhibitor–1 in Healthy Middle-aged Men
1996
Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome
2011
Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes
2003
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
2001 Standout
Targeting G βγ signaling in arterial vascular smooth muscle proliferation: A novel strategy to limit restenosis
1999 StandoutNobel
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
1998 Standout
Mechanisms of platelet activation: Thromboxane A2 as an amplifying signal for other agonists
1991
Diagnosing and managing unstable angina. Agency for Health Care Policy and Research.
1994
Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction
1998
Acute Coronary Syndromes
1998
Aspirin and Other Platelet-Active Drugs
1992
Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.
1994
Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease
1990
Appropriate use of heparin. Empiric vs nomogram-based dosing.
1995
Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.
1994
Unstable angina. A classification.
1989
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization
1997 Standout
2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
2012
Intracoronary Thrombus and Platelet Glycoprotein IIb/IIIa Receptor Blockade With Tirofiban in Unstable Angina or Non–Q-Wave Myocardial Infarction
1999
Hemorrhagic Complications of Anticoagulant Treatment
1992
Evidence for reduced fibrinolytic activity in unstable angina at rest. Clinical, biochemical, and angiographic correlates.
1991
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina.
1993
A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes
1996
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Clinical Aspects of Platelet Inhibitors and Thrombus Formation
2007
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Low-Molecular-Weight Heparins
1997 Standout
Assessment of the Treatment Effect of Enoxaparin for Unstable Angina/Non–Q-Wave Myocardial Infarction
1999
Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group.
1994
Hemorrhagic Complications of Anticoagulant Treatment
1995
Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials.
1993
Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease
1991
Adding Heparin to Aspirin Reduces the Incidence of Myocardial Infarction and Death in Patients With Unstable Angina
1996
Association Between Increased Estrogen Status and Increased Fibrinolytic Potential in the Framingham Offspring Study
1995
Plasma Protein Acute-Phase Response in Unstable Angina Is Not Induced by Ischemic Injury
1996
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Transient intermittent lymphocyte activation is responsible for the instability of angina.
1992
Artificial damping techniques for scalar waves in the frequency domain
1996
Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects.
1989
The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation
1990 Standout
Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study (CARPORT).
1991
Works of Patrick Joly being referenced
Restenosis and progression of coronary atherosclerosis after coronary angioplasty
1988
Aspirin, Heparin, or Both to Treat Acute Unstable Angina
1988
Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response.
1989
Mathematical and Numerical Aspects of Wave Propagation Phenomena
1991
[Has the prognosis of recent myocardial infarction changed?].
1987